In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization (EUA) or approved by the Food and Drug Administration (FDA), an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results.
Click here for original story, Mix-and-match trial finds additional dose of COVID-19 vaccine safe, immunogenic
Source: ScienceDaily